The Food and Drug Administration (FDA) conducted an inspection at LifeStream Blood Bank in Placentia on Feb. 5 focused on blood and blood products, according to information available on the FDA’s website.
The inspection report concluded that LifeStream Blood Bank was not required to address or change any of its management operations.
The FDA routinely inspects facilities nationwide to ensure workplaces and products adhere to FDA-mandated laws and regulations that aim to enhance public health. Results from these inspections are made available to the public.
As stated on its official website, the FDA is a federal agency charged with overseeing the safety and quality of human and animal drugs, biological goods, medical supplies and tobacco products.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
